肿瘤科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 肿瘤科威廉亚洲博彩公司

2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告

2020-08-28 Korean J Radiol . 2020 Aug 28.

肝外胆管癌

2020年8月，韩国腹部放射学会(KSAR)发布了肝外胆管癌的影像学评估和结构化报告共识建议的英文版本。影像学检查对于评估肝外胆管癌具有重要意义，主要用于肿瘤分期和评估手术切除的适宜性。本文主要针对肝

中文标题：

2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告

英文标题：

Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology

发布机构：

发布日期：

2020-08-28

简要介绍：

2020年8月，韩国腹部放射学会(KSAR)发布了肝外胆管癌的影像学评估和结构化报告共识建议的英文版本。影像学检查对于评估肝外胆管癌具有重要意义，主要用于肿瘤分期和评估手术切除的适宜性。本文主要针对肝外胆管癌的影像学评估和结构化报告的相关内容提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2ba9a1c00198eab0, title=2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告, enTitle=Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology, guiderFrom=Korean J Radiol . 2020 Aug 28., authorId=0, author=, summary=2020年8月，韩国腹部放射学会(KSAR)发布了肝外胆管癌的影像学评估和结构化报告共识建议的英文版本。影像学检查对于评估肝外胆管癌具有重要意义，主要用于肿瘤分期和评估手术切除的适宜性。本文主要针对肝, cover=https://img.medsci.cn/2020106/1601996719059_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Aug 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，韩国腹部放射学会(KSAR)发布了肝外胆管癌的影像学评估和结构化报告共识建议的英文版本。影像学检查对于评估肝外胆管癌具有重要意义，主要用于肿瘤分期和评估手术切除的适宜性。本文主要针对肝外胆管癌的影像学评估和结构化报告的相关内容提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=104875, tagName=肝外胆管癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=104875, guiderKeyword=肝外胆管癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2376, appHits=137, showAppHits=0, pcHits=495, showPcHits=2239, likes=0, shares=14, comments=9, approvalStatus=1, publishedTime=Wed Oct 07 00:06:44 CST 2020, publishedTimeString=2020-08-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 06 23:05:26 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:41:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告.pdf)])
2019 KSAR共识建议：肝外胆管癌的影像学评估和结构化报告.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228238, encodeId=8c641228238ff, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:32:45 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007708, encodeId=f68f100e70844, content=看不了，能不能分享下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Fri Aug 13 19:57:09 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004615, encodeId=3d881004615f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6af5466282, createdName=aaalrx, createdTime=Mon Aug 02 13:22:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900886, encodeId=a9c09008860a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36fa1961702, createdName=平平安安, createdTime=Fri Nov 20 19:24:37 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890717, encodeId=ef33890e176f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Fri Oct 09 09:26:42 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2022-06-23 145d4c03m99暂无昵称

    有意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228238, encodeId=8c641228238ff, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:32:45 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007708, encodeId=f68f100e70844, content=看不了，能不能分享下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Fri Aug 13 19:57:09 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004615, encodeId=3d881004615f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6af5466282, createdName=aaalrx, createdTime=Mon Aug 02 13:22:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900886, encodeId=a9c09008860a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36fa1961702, createdName=平平安安, createdTime=Fri Nov 20 19:24:37 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890717, encodeId=ef33890e176f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Fri Oct 09 09:26:42 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2021-08-13 ms9000000105540481

    看不了，能不能分享下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1228238, encodeId=8c641228238ff, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:32:45 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007708, encodeId=f68f100e70844, content=看不了，能不能分享下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Fri Aug 13 19:57:09 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004615, encodeId=3d881004615f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6af5466282, createdName=aaalrx, createdTime=Mon Aug 02 13:22:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900886, encodeId=a9c09008860a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36fa1961702, createdName=平平安安, createdTime=Fri Nov 20 19:24:37 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890717, encodeId=ef33890e176f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Fri Oct 09 09:26:42 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2021-08-02 aaalrx

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1228238, encodeId=8c641228238ff, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:32:45 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007708, encodeId=f68f100e70844, content=看不了，能不能分享下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Fri Aug 13 19:57:09 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004615, encodeId=3d881004615f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6af5466282, createdName=aaalrx, createdTime=Mon Aug 02 13:22:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900886, encodeId=a9c09008860a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36fa1961702, createdName=平平安安, createdTime=Fri Nov 20 19:24:37 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890717, encodeId=ef33890e176f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Fri Oct 09 09:26:42 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2020-11-20 平平安安

    好文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1228238, encodeId=8c641228238ff, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:32:45 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007708, encodeId=f68f100e70844, content=看不了，能不能分享下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da1f5556950, createdName=ms9000000105540481, createdTime=Fri Aug 13 19:57:09 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004615, encodeId=3d881004615f8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6af5466282, createdName=aaalrx, createdTime=Mon Aug 02 13:22:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900886, encodeId=a9c09008860a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36fa1961702, createdName=平平安安, createdTime=Fri Nov 20 19:24:37 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890717, encodeId=ef33890e176f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Fri Oct 09 09:26:42 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2020-10-09 ms6000001515816393

    学习

    0